vs

Side-by-side financial comparison of PROGRESS SOFTWARE CORP (PRGS) and Protagonist Therapeutics, Inc (PTGX). Click either name above to swap in a different company.

PROGRESS SOFTWARE CORP is the larger business by last-quarter revenue ($252.7M vs $170.6M, roughly 1.5× Protagonist Therapeutics, Inc). Protagonist Therapeutics, Inc runs the higher net margin — 77.2% vs 10.2%, a 67.0% gap on every dollar of revenue. On growth, Protagonist Therapeutics, Inc posted the faster year-over-year revenue change (184.4% vs 17.5%). Protagonist Therapeutics, Inc produced more free cash flow last quarter ($182.8M vs $59.9M).

Progress Software Corporation develops and sells enterprise software products including application development platforms, data connectivity tools, and digital experience solutions. It serves global enterprise clients across finance, healthcare, manufacturing, retail and other sectors, helping organizations build scalable, high-performance business applications and streamline operational workflows.

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel peptide-based targeted therapies for unmet medical needs, primarily covering gastrointestinal disorders, inflammatory diseases and rare disease indications. Its lead product candidates target inflammatory bowel disease and other chronic immune-related conditions, with operations spanning global R&D and partnership collaborations.

PRGS vs PTGX — Head-to-Head

Bigger by revenue
PRGS
PRGS
1.5× larger
PRGS
$252.7M
$170.6M
PTGX
Growing faster (revenue YoY)
PTGX
PTGX
+166.9% gap
PTGX
184.4%
17.5%
PRGS
Higher net margin
PTGX
PTGX
67.0% more per $
PTGX
77.2%
10.2%
PRGS
More free cash flow
PTGX
PTGX
$122.9M more FCF
PTGX
$182.8M
$59.9M
PRGS

Income Statement — Q4 FY2025 vs Q4 FY2024

Metric
PRGS
PRGS
PTGX
PTGX
Revenue
$252.7M
$170.6M
Net Profit
$25.7M
$131.7M
Gross Margin
81.6%
Operating Margin
15.2%
74.3%
Net Margin
10.2%
77.2%
Revenue YoY
17.5%
184.4%
Net Profit YoY
2144.6%
381.7%
EPS (diluted)
$0.59
$2.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRGS
PRGS
PTGX
PTGX
Q4 25
$252.7M
Q3 25
$249.8M
Q2 25
$237.4M
Q1 25
$238.0M
Q4 24
$215.0M
$170.6M
Q3 24
$178.7M
Q2 24
$175.1M
Q1 24
$184.7M
$255.0M
Net Profit
PRGS
PRGS
PTGX
PTGX
Q4 25
$25.7M
Q3 25
$19.4M
Q2 25
$17.0M
Q1 25
$10.9M
Q4 24
$1.1M
$131.7M
Q3 24
$28.5M
Q2 24
$16.2M
Q1 24
$22.6M
$207.3M
Gross Margin
PRGS
PRGS
PTGX
PTGX
Q4 25
81.6%
Q3 25
81.0%
Q2 25
80.1%
Q1 25
80.6%
Q4 24
83.0%
Q3 24
83.7%
Q2 24
81.7%
Q1 24
82.2%
Operating Margin
PRGS
PRGS
PTGX
PTGX
Q4 25
15.2%
Q3 25
17.6%
Q2 25
16.3%
Q1 25
13.6%
Q4 24
10.0%
74.3%
Q3 24
22.6%
Q2 24
15.5%
Q1 24
19.0%
80.9%
Net Margin
PRGS
PRGS
PTGX
PTGX
Q4 25
10.2%
Q3 25
7.8%
Q2 25
7.2%
Q1 25
4.6%
Q4 24
0.5%
77.2%
Q3 24
15.9%
Q2 24
9.2%
Q1 24
12.3%
81.3%
EPS (diluted)
PRGS
PRGS
PTGX
PTGX
Q4 25
$0.59
Q3 25
$0.44
Q2 25
$0.39
Q1 25
$0.24
Q4 24
$0.01
$2.01
Q3 24
$0.65
Q2 24
$0.37
Q1 24
$0.51
$3.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRGS
PRGS
PTGX
PTGX
Cash + ST InvestmentsLiquidity on hand
$94.8M
$418.9M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$478.3M
$675.3M
Total Assets
$2.5B
$744.7M
Debt / EquityLower = less leverage
2.93×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRGS
PRGS
PTGX
PTGX
Q4 25
$94.8M
Q3 25
$99.0M
Q2 25
$102.0M
Q1 25
$124.2M
Q4 24
$118.1M
$418.9M
Q3 24
$232.7M
Q2 24
$190.4M
Q1 24
$133.2M
$322.6M
Total Debt
PRGS
PRGS
PTGX
PTGX
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PRGS
PRGS
PTGX
PTGX
Q4 25
$478.3M
Q3 25
$477.7M
Q2 25
$452.7M
Q1 25
$431.8M
Q4 24
$438.8M
$675.3M
Q3 24
$425.6M
Q2 24
$401.7M
Q1 24
$461.7M
$560.4M
Total Assets
PRGS
PRGS
PTGX
PTGX
Q4 25
$2.5B
Q3 25
$2.4B
Q2 25
$2.4B
Q1 25
$2.5B
Q4 24
$2.5B
$744.7M
Q3 24
$1.6B
Q2 24
$1.6B
Q1 24
$1.5B
$629.3M
Debt / Equity
PRGS
PRGS
PTGX
PTGX
Q4 25
2.93×
Q3 25
2.97×
Q2 25
3.22×
Q1 25
3.50×
Q4 24
3.48×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRGS
PRGS
PTGX
PTGX
Operating Cash FlowLast quarter
$62.8M
$184.2M
Free Cash FlowOCF − Capex
$59.9M
$182.8M
FCF MarginFCF / Revenue
23.7%
107.1%
Capex IntensityCapex / Revenue
1.1%
0.8%
Cash ConversionOCF / Net Profit
2.44×
1.40×
TTM Free Cash FlowTrailing 4 quarters
$229.5M
$101.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRGS
PRGS
PTGX
PTGX
Q4 25
$62.8M
Q3 25
$73.4M
Q2 25
$30.0M
Q1 25
$68.9M
Q4 24
$19.7M
$184.2M
Q3 24
$57.7M
Q2 24
$63.7M
Q1 24
$70.5M
$-27.4M
Free Cash Flow
PRGS
PRGS
PTGX
PTGX
Q4 25
$59.9M
Q3 25
$72.4M
Q2 25
$29.5M
Q1 25
$67.7M
Q4 24
$16.8M
$182.8M
Q3 24
$56.6M
Q2 24
$62.7M
Q1 24
$70.2M
$-27.7M
FCF Margin
PRGS
PRGS
PTGX
PTGX
Q4 25
23.7%
Q3 25
29.0%
Q2 25
12.4%
Q1 25
28.4%
Q4 24
7.8%
107.1%
Q3 24
31.7%
Q2 24
35.8%
Q1 24
38.0%
-10.9%
Capex Intensity
PRGS
PRGS
PTGX
PTGX
Q4 25
1.1%
Q3 25
0.4%
Q2 25
0.2%
Q1 25
0.5%
Q4 24
1.3%
0.8%
Q3 24
0.6%
Q2 24
0.5%
Q1 24
0.2%
0.1%
Cash Conversion
PRGS
PRGS
PTGX
PTGX
Q4 25
2.44×
Q3 25
3.78×
Q2 25
1.76×
Q1 25
6.30×
Q4 24
17.13×
1.40×
Q3 24
2.03×
Q2 24
3.93×
Q1 24
3.11×
-0.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRGS
PRGS

Maintenanceand Services$187.5M74%
Share File Acquisition$67.5M27%

PTGX
PTGX

Segment breakdown not available.

Related Comparisons